Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Titel:
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Auteur:
Bigal, Marcelo E Dodick, David W Rapoport, Alan M Silberstein, Stephen D Ma, Yuju Yang, Ronghua Loupe, Pippa S Burstein, Rami Newman, Lawrence C Lipton, Richard B